To make an appointment, please call 1-800-KARMANOS (1-800-527-6266) or request an appointment online
As a leader in cancer research, Karmanos is able to offer patients access to innovative treatments and clinical trials that are often times not available anywhere else.
To offer hope and longer life to patients with all types of cancer, Karmanos offers the latest types of therapy through our clinical trials program. Through clinical trials, we are creating new knowledge about how therapies fight cancer and provide national leadership in testing these new therapies.
We understand that cancer is a complex disease that demands complex care. We provide each patient with a dynamic, carefully constructed treatment plan focused on their specific cancer and their unique needs.
We listen to you to design a plan that provides you with respect, compassionate care and is responsive to your emotional and practical concerns.
The underlying mission of the Molecular Therapeutics (MT) Program is to translate laboratory findings to the clinic so as to improve the lives of patients with cancer by identifying new molecules, targets and strategies for treating cancer. This highly interactive program includes a cross section of laboratory-based scientists and physicians at Karmanos who meet regularly through programmatic activities, and serve as co-investigators on research grants and investigator-initiated clinical trials.
The MT Program’s overriding goal is to integrate basic and translational scientists working broadly in areas of drug development, new or established therapeutic targets or pathways, and cellular and genetic biomarkers of cancer, with physicians conducting interventional treatment trials at the Karmanos Cancer Institute.
The MT Program leadership actively supports:
Eunice and Milton Ring Endowed Chair for Cancer Research Professor & Director, Cancer Biology Graduate Program Associate Center Director for Basic Sciences Molecular Therapeutics Program Leader Barbara Ann Karmanos Cancer Institute Wayne State University School of Medicine matherly@karmanos.org
Kathryn Cramer Endowed Chair in Cancer Research Vice President of Medical Affairs Multidisciplinary Team Leader, GI and Neuroendocrine Tumor Molecular Therapeutics Program Co-Leader Barbara Ann Karmanos Cancer Institute Professor, Department of Oncology Wayne State University School of Medicine philipp@karmanos.org
Leader, Multiple Myeloma Sub-Committee Molecular Therapeutics Program Co-Leader Barbara Ann Karmanos Cancer Institute Professor, Departments of Hematology & Oncology Wayne State University School of Medicine zonderj@karmanos.org
The Barbara Ann Karmanos Cancer Institute is pleased to announce the winners of its 2021 Heroes of Cancer Awards. This year's event celebrates Kar...
The Barbara Ann Karmanos Cancer Institute is pleased to announce that it has entered into a partnership with The Toledo Clinic to establish a new ...
After serving for 20 years in the United States Navy as a submarine sailor, John Lacks retired and transitioned to life with his family, including...